Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00237783 · ClinicalTrials.gov registry record · Phase 1
Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension
A Phase 1 study, sponsored by Yale University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT00237783: Clinical Trial Phase 1 study, sponsored by Yale University.
NCT00237783 is a Phase 1 study that was terminated before completion, run by Yale University. The registered enrollment target is 4 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00237783, a Phase 1 study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
Low blood pressure (hypotension) during dialysis afflicts approximately 25% of hemodialysis patients. In this pilot study, we will evaluate the safety and effects of individualizing the sodium concentration in the dialysate according to the patient's own plasma sodium levels. We hypothesize that patients will have less thirst and less weight gain during the intervention leading to easier fluid removal and less episodes of hypotension.
Interventions
- DRUG dialysate sodium (140 mmol/L)
- DRUG individualized dialysate sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Why NCT00237783 stopped before completion
NCT00237783 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which dialysate sodium (140 mmol/L) is the first listed.
NCT00237783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00237783 about?
NCT00237783 is a clinical study titled "Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension". Low blood pressure (hypotension) during dialysis afflicts approximately 25% of hemodialysis patients. In this pilot study, we will evaluate the safety and effects of individualizing the sodium concentration in the dialysate according to the patient's own plasma sodium levels. We hypothesize that pat...
What is the current status of trial NCT00237783?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2005-10. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00237783?
The interventions under investigation include: dialysate sodium (140 mmol/L) (DRUG), individualized dialysate sodium (DRUG).
Who is sponsoring clinical trial NCT00237783?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00237783's enrollment target sits among peer trials
4 1995th of 2000 higher than 2 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia